☰ Accessibility
November 12, 2025

MTAR Technologies Limited announced that it has received new orders valued at ₹271.75 crore (approximately $30.88 million) from an existing international customer. Order Details The company disclosed the development on November 12, 2025, stating that the customer’s identity remains confidential under non-disclosure agreements. The orders are part of…

November 12, 2025

Fortis Healthcare Limited reported a strong financial performance for the quarter ended September 30, 2025, with consolidated net profit rising 82% year-on-year to ₹321 crore, compared with ₹176.5 crore in the same period last year. The growth was driven by solid operational performance across both the hospital and…

November 12, 2025

Tata Consultancy Services (TCS) has announced a partnership with SINTEF, one of Europe’s largest independent research foundations, to develop AI-driven solutions aimed at improving elderly care and supporting independent living for senior citizens. Enhancing the SMILE Platform The collaboration will focus on advancing SINTEF’s Smart Inclusive Living Environments…

Latest Updates
November 12, 2025

IOL Chemicals and Pharmaceuticals Ltd reported a strong performance for the September 2025 quarter, posting a significant rise in profitability and operational efficiency. The company’s shares surged up to 13% during the session, reversing a recent downward trend. Financial Highlights (Q2 FY25, YoY) Net Profit: ₹30 crore, up…

November 12, 2025

Furniture and home-furnishing retailer IKEA India reported a 6% year-on-year increase in sales, with annual revenue reaching ₹1,860.8 crore for the financial year ended August 2025. The company’s Swedish parent, Ingka Group, which follows a September–August financial cycle, announced global revenues of €41.5 billion, marking a marginal decline…

Latest Updates
November 12, 2025

Zydus Lifesciences Ltd has received approval from China’s National Medical Products Administration (NMPA) to market Venlafaxine extended-release capsules in 75 mg and 150 mg strengths. First Approval in China This marks Zydus Lifesciences’ first regulatory approval in China, representing a key milestone in the company’s expansion into the…